rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
8
|
pubmed:dateCreated |
2000-9-6
|
pubmed:abstractText |
Vascular endothelial growth factor (VEGF) is being investigated for therapeutic angiogenesis in ischemic myocardium. Primarily, transient delivery systems have been tested. The goal of this study was to investigate the effects of continuous expression of VEGF in myocardium by use of myoblast-mediated delivery.
|
pubmed:grant |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
1524-4539
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:day |
22
|
pubmed:volume |
102
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
898-901
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:10952959-Animals,
pubmed-meshheading:10952959-Cell Transplantation,
pubmed-meshheading:10952959-Endothelial Growth Factors,
pubmed-meshheading:10952959-Gene Expression Regulation,
pubmed-meshheading:10952959-Gene Transfer Techniques,
pubmed-meshheading:10952959-Heart Neoplasms,
pubmed-meshheading:10952959-Hemangioma,
pubmed-meshheading:10952959-Lymphokines,
pubmed-meshheading:10952959-Male,
pubmed-meshheading:10952959-Mice,
pubmed-meshheading:10952959-Mice, Inbred C57BL,
pubmed-meshheading:10952959-Mice, SCID,
pubmed-meshheading:10952959-Muscle, Skeletal,
pubmed-meshheading:10952959-Myocardium,
pubmed-meshheading:10952959-Vascular Endothelial Growth Factor A,
pubmed-meshheading:10952959-Vascular Endothelial Growth Factors
|
pubmed:year |
2000
|
pubmed:articleTitle |
VEGF gene delivery to myocardium: deleterious effects of unregulated expression.
|
pubmed:affiliation |
Department of Medicine and the Cardiovascular Research Institute, University of California, San Francisco, USA. lee@ep4.ucsf.edu
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|